The FDA approved a new blood test developed by Roche in partnership with Eli Lilly to help identify amyloid pathology linked to Alzheimer’s Disease.
One America’s Stephanie Myers speaks with the senior medical manager in neurology for Roche, Joshua Kulas, about the development.
Join this channel to get access to OAN Live & perks:
https://www.youtube.com/channel/UCNbIDJNNgaRrXOD7VllIMRQ/join
Visit us On
OAN Live : https://live.oann.com/home.ktv
Website: https://www.oann.com
Facebook: https://www.facebook.com/OneAmericaNewsNetwork
Twitter: https://twitter.com/OANN
Instagram: https://www.instagram.com/one_america_news_
KlowdTV:
Watch OAN Live on KlowdTV subscription prices start at $2.99 /mo
https://klowdtv.com